تداخل‌های دارویی
Denosumab + Efgartigimod alfa
شدت: متوسط
Denosumab and Efgartigimod alfa: moderate interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Efgartigimod blocks the neonatal Fc receptor, which recycles IgG and protects it from degradation. Denosumab is an IgG2 antibody, so its exposure and bone-protective effect could theoretically fall. Clinical data are lacking.
معنای این تداخل به زبان ساده
Denosumab and Efgartigimod alfa can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Denosumab belongs to Oncology; Efgartigimod alfa belongs to Miscellaneous.
چرا رخ می‌دهد
FcRn blockade accelerates IgG catabolism and may lower denosumab concentrations.
اقدام لازم
Monitor bone turnover markers and bone density response, and watch for loss of effect such as rising resorption markers. If denosumab is essential long term, consider the timing of efgartigimod cycles or alternative antiresorptives.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Denosumab و Efgartigimod alfa، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Denosumab
- Abatacept + Denosumab متوسط
- Adalimumab + Denosumab متوسط
- Alefacept + Denosumab متوسط
- Alemtuzumab + Denosumab متوسط
- Anakinra + Denosumab متوسط
- Azacitidine + Denosumab متوسط
تداخلات دیگر Efgartigimod alfa
پرسش‌های متداول
Can I take Denosumab with Efgartigimod alfa?
MediHelp rates the interaction as moderate. Denosumab and Efgartigimod alfa can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efgartigimod blocks the neonatal Fc receptor, which recycles IgG and protects it from degradation. Denosumab is an IgG2 antibody, so its exposure and bone-protective effect could theoretically fall. Clinical data are lacking.
How serious is the interaction between Denosumab and Efgartigimod alfa?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor bone turnover markers and bone density response, and watch for loss of effect such as rising resorption markers. If denosumab is essential long term, consider the timing of efgartigimod cycles or alternative antiresorptives.
What other medicines interact with Denosumab?
MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
